Corporate digest

Lonza Group

CHEMICALS and biotech company Lonza Group will buy a sterile drug product fill-and-finish facility in Stein, Switzerland, from Novartis. Lonza, which has a secondary listing on the Singapore Exchange, said it had entered into a binding contractual commitment for the acquisition, but did not disclose the purchase price.

It will use the facility to manufacture drug products for Novartis, as well as to provide production capacity for its additional customers.

New Silkroutes Group

NEW Silkroutes Group (NSG) has announced that the sale and purchase agreement for the disposal of International Energy Group (IEG) to TK Energy has lapsed as at June 30, with the buyer having failed to disburse the loans to New Silkroutes Capital (NSC) and IEG under the respective loan agreements. The buyer has not demonstrated its ability to inject the required capital into IEG for its business, NSG said, adding that it will continue to look for a suitable buyer with the financial means to maintain and grow IEG's…